Erratum: Association between the G1001C polymorphism in the GRIN1 gene promoter and schizophrenia in the Iranian population (J Mol Neurosci Doi: 10.1007/s12031-008-9148-5);Association between the G1001C polymorphism in the GRIN1 gene promoter and schizophrenia in the iranian population

Journal of Molecular Neuroscience

Volumn 38, Issue 2, 2009, Pages 178-181

  Galehdari, Hamid ^a  

^a SHAHID CHAMRAN UNIVERSITY OF AHVAZ   (Iran)

Author keywords

Association study; Functional polymorphism; GRIN1; Ionotropic glutamate receptor; Promoter region; Schizophrenia

Indexed keywords

ADULT; ALLELE; ARTICLE; CASE CONTROL STUDY; CONTROLLED STUDY; DISEASE ASSOCIATION; DISEASE PREDISPOSITION; DNA POLYMORPHISM; FEMALE; GENE; GENE FREQUENCY; GENETIC RISK; GENETIC VARIABILITY; GENOTYPE; GRIN1 GENE; HUMAN; IRAN; MAJOR CLINICAL STUDY; MALE; POLYMERASE CHAIN REACTION; PROMOTER REGION; RESTRICTION FRAGMENT LENGTH POLYMORPHISM; SCHIZOPHRENIA; DNA SEQUENCE; ETHNIC GROUP; GENETIC POLYMORPHISM; GENETICS; MIDDLE AGED; PATHOPHYSIOLOGY;

CARRIER PROTEIN; GRIN1 PROTEIN, HUMAN; N METHYL DEXTRO ASPARTIC ACID RECEPTOR; NERVE PROTEIN;

ADULT; CARRIER PROTEINS; CASE-CONTROL STUDIES; ETHNIC GROUPS; GENE FREQUENCY; GENOTYPE; HUMANS; IRAN; MIDDLE AGED; NERVE TISSUE PROTEINS; POLYMORPHISM, GENETIC; PROMOTER REGIONS, GENETIC; RECEPTORS, N-METHYL-D-ASPARTATE; SCHIZOPHRENIA; SEQUENCE ANALYSIS, DNA;

EID: 69249231191     PISSN: 08958696     EISSN: None     Source Type: Journal    
DOI: 10.1007/s12031-008-9152-9     Document Type: Erratum

References (28)

1. Allen, N. C., Bagade, S., McQueen, M. B., et al. (2008). Systematic meta-analyses and field synopsis of genetic association studies in schizophrenia: The SzGene database. Nature Genetics, 40(7), 827-834. doi:10.1038/ng.171. (Pubitemid 351913655)
2. Begni, S., Moraschi, S., Bignotti, S., et al. (2003). Association between the G1001C polymorphism in the GRIN1 gene promoter region and schizophrenia. Biological Psychiatry, 53, 617-619. doi:10.1016/S0006-3223(02)01783-3. (Pubitemid 36385063)
3. Bertram, L. (2008). Genetic research in schizophrenia: New tools and future perspectives. Schizophrenia Bulletin, 34, 806-812.
4. Daw, N. W., Stein, P. S. G., Fox, K., et al. (1993). The role of NMDA receptors in information processing. Annual Review of Neuroscience 16, 207-222.
5. Faraone, S. V., Matise, T., Svrakic, D., et al. (1998). Genome scan of European-American schizophrenia pedigrees: Results of the NIMH Genetics Initiative and Millennium Consortium. American Journal of Medical Genetics, 81, 290-295. doi:10.1002/(SICI)1096-8628(19980710)81:4<290::AID-AJMG3>3.0.CO;2-Y. (Pubitemid 28294809)
6. Fujii, D. E., Wylie, A. M., & Nathan, J. H. (2004). Neurocognition and long-term prediction of quality of life in outpatients with severe and persistent mental illness. Schizophrenia Research, 69, 67-73. doi:10.1016/S0920-9964(03)00122-1. (Pubitemid 38625760)
7. Georgi, A., Jamra, R. A., Klein, K. B., et al. (2007). Possible association between genetic variants at the GRIN1 gene and schizophrenia with lifetime history of depressive symptoms in a German sample. Psychiatric Genetics, 17(5), 308-310. doi:10.1097/YPG.0b013e3280c1e5fb. (Pubitemid 47345754)
8. Goff, D. C., & Coyle, J. T. (2001). The emerging role of glutamate in the pathophysiology and treatment of schizophrenia. The American Journal of Psychiatry, 158, 1367-1377. doi:10.1176/appi.ajp.158.9.1367. (Pubitemid 32847232)
9. Harrison, P. J., & Weinberger, D. R. (2005). Schizophrenia genes, gene expression, and neuropathology: On the matter of their convergence. Molecular Psychiatry, 10, 40-68. doi:10.1038/sj.mp.4001558. (Pubitemid 40139588)
10. Hollmann, M., & Heinemann, S. (1994). Cloned glutamate receptors. Annual Review of Neuroscience, 17, 31-108. doi:10.1146/annurev.ne.17.030194.000335.
11. Hung, C. C., Chen, H. Y., & Chen, C. H. (2002). Systematic mutation analysis of the human glutamate receptor, ionotropic, N-methyl-Daspartate 1 gene (GRIN1) in schizophrenic patients. Psychiatric Genetics, 12, 225-230. doi:10.1097/00041444-200212000-00005. (Pubitemid 36026932)
12. Jablensky, A. (2000). Epidemiology of schizophrenia: the global burden of disease and disability. European Archives of Psychiatry and Clinical Neuroscience, 250, 274-285. doi:10.1007/s004060070002.
13. Javitt, D. C., & Zukin, S. R. (1991). Recent advances in the phencyclidine model of schizophrenia. The American Journal of Psychiatry, 148, 1301-1308.
14. Karasawa, J., Hashimoto, K., & Chali, S. H. (2008). d-Serine and a glycine transporter inhibitor improve MK-801-inducedcognitive deficits in a novel object recognition test in rats. Behavioural Brain Research, 186, 78-83. doi:10.1016/j.bbr.2007.07.033. (Pubitemid 350100896)
15. Lane, H. Y., Chang, Y. C., Liu, Y. C., Chiu, C. C., & Tsai, G. E. (2005). Sarcosine or D-serine add-on treatment for acute exacerbation of schizophrenia: a randomized, double blind, placebo-controlled study. Archives of General Psychiatry, 62, 1196-1204. doi:10.1001/archpsyc.62.11.1196. (Pubitemid 41586919)
16. Martucci, L., Wong, A. H., Trakalo, J., et al. (2003). N-methyl-Daspartate receptor NR1 subunit gene (GRIN1) in schizophrenia: TDT and case-control analyses. American Journal of Medical Genetics, 119B, 24-27. doi:10.1002/ajmg.b.20014.
17. McGuffin, P., Tandon, K., & Corsico, A. (2003). Linkage and association studies of schizophrenia. Current Psychiatry Reports, 5(2), 121-127. doi:10.1007/s11920-003-0028-y.
18. Meador-Woodruff, J. H., & Healy, D. J. (2000). Glutamate receptor expression in schizophrenic brain. Brain Research Review, 31, 288-294.
19. Mohn, A. R., Gainetdinov, R. R., Caron, M. G., & Koller, B. H. (1999). Mice with reduced NMDA receptor expression display behaviors related to schizophrenia. Cell, 98, 427-436. doi:10.1016/S0092-8674(00)81972-8. (Pubitemid 29402481)
20. Monyer, H., Sprengel, R., Schoepfer, R., et al. (1992). Heteromeric NMDA receptors: Molecular and functional distinction of subtypes. Science, 256, 1217-1221. doi:10.1126/science.256.5060.1217.
21. Qin, S. H., Zhao, X., Pan, Y., et al. (2005). An association study of the N-methyl-D-aspartate receptor NR1 subunit gene (GRIN1) and NR2B subunit gene (GRIN2B) in schizophrenia with universal DNA microarray. European Journal of Human Genetics, 13, 807-814. doi:10.1038/sj.ejhg.5201418. (Pubitemid 40946078)
22. Rice, S. R., Niu, N., Berman, D. B., Heston, L. L., & Sobell, J. L. (2001). Identification of single nucleotide polymorphisms (SNPs) and other sequence changes and estimation of nucleotide diversity in coding and flanking regions of the NMDAR1 receptor gene in schizophrenic patients. Molecular Psychiatry, 6, 274-284. doi:10.1038/sj.mp.4000838. (Pubitemid 32275672)
23. Sakurai, K., Toru, M., Yamakawa-Kobayashi, K., & Arinami, T. (2000). Mutation analysis of the N-methyl-D-aspartate receptor NR1 subunit gene (GRIN1) in schizophrenia. Neuroscience Letters, 296, 168-170. doi:10.1016/S0304-3940(00)01599-8.
24. Schork, N. J., Greenwood, T. A., & Braff, D. L. (2006). Statistical genetics concepts and approaches in schizophrenia and related neuropsychiatric research. Schizophrenia Bulletin, 33(1), 95-104. doi:10.1093/schbul/sbl045.
25. Tani, A., Kikuta, R., Itoh, K., et al. (2002). Polymorphism analysis of the upstream region of the human N-methyl-D-aspartate receptor upstream region of the human N-methyl-D-aspartate receptor subunit NR1 gene (GRIN1): Implications for schizophrenia. Schizophrenia Research, 58, 83-86. doi:10.1016/S0920-9964(02)00161-165
26. VanDongen, A. M., & Van Dongen, H. M. (2004). Effects of mRNA untranslated regions on translational efficiency of NMDA receptor subunits. Neuro-Signals, 13, 194-206. doi:10.1159/000077526. (Pubitemid 38698092)
27. Williams, N. M., Bowen, T., Spurlock, G., et al. (2002). Determination of the genomic structure and mutation screening in schizophrenic individuals for five subunits of the N-methyl-Daspartate glutamate receptor. Molecular Psychiatry, 7, 508-514. doi:10.1038/sj.mp.4001030. (Pubitemid 34712903)
28. Zhao, X., Li, H., Shi, Y., et al. (2006). Signification association between the genetic variations in the 5 end of the N-methyl-Daspartate receptor subunit gene GRIN1 and schizophrenia. Biological Psychiatry, 59, 747-753. doi:10.1016/j.biopsych.2005.10.023.